Search

everythinglearnresearchcommunity

for

Search:↓

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Imatinib can cause hair loss due to lichen planopilaris.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

The patch effectively promotes hair growth for alopecia areata without pain.

Different tumor cells in one basal cell carcinoma can cause mixed treatment responses, suggesting personalized treatment is needed.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Zebularine improved skin structure but delayed wound healing in diabetic mice.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.